Skip to content
Search

Latest Stories

£40 million investment to update outdated NHS tech

The government has announced a £40 million investment in frontline technology as the current outdated systems sometimes force NHS staff to log into as many as 15 different computer programmes.

The ‘logins project’ is expected to ease the administrative burden on NHS staff, freeing up time for more one-to-one patient care.


The existing programmes require staff to remember multiple complex passwords or use the same one on multiple systems, causing a cybersecurity risk.

Health and Social Care Secretary Matt Hancock said: “As I visit hospitals and GP practices around the country, I’ve lost count of the amount of times staff complain about this. It’s no good in the 21st century having 20th-century technology at work. This investment is committed to driving forward the most basic frontline technology upgrades, so treatment can be delivered more effectively and we can keep pace with the growing demand on the NHS.”

A single sign-on technology implemented at Alder Hey Hospital in Liverpool has reduced time spent logging into multiple computer systems from 1 minute 45 seconds to just 10 seconds.

The investment will support similar projects which help NHS staff to focus more on patient care.

The project will focus on:

  • working with IT system suppliers to standardise logins and provide multi-factor logins, like fingerprint access, rather than password-led logins
  • ensuring trusts update their processes to give staff appropriate access permissions for the systems they need to treat patients
  • integrating local and national systems so staff can access the full range of clinical and workforce systems to support their needs.

Chief Executive of NHSX, Matthew Gould, said: If you work in the NHS, the tech should not be getting in the way of your ability to do your job. Tech should be something you rarely think about because it just works... It will allow staff across the NHS to spend more time with their patients and less time fighting their computers."

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less